Evidence map›Paper›PMID 35216303›Full record

ArticleInternational journal of molecular sciences2022

Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand.

Serena Carrara, Florent Rouvier, Sanjana Auditto, Frédéric Brunel, Charlotte Jeanneau, Michel Camplo, Michelle Sergent, Imad About, Jean-Michel Bolla, Jean-Manuel Raimundo

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Serena CarraraAix-Marseille Université, CNRS, CINAM, 13288 Marseille, France.ORCID 0000-0001-8921-7094
Florent RouvierAix-Marseille Université, INSERM, SSA, IRBA, MCT, 13005 Marseille, France.
Sanjana AudittoAix-Marseille Université, CNRS, CINAM, 13288 Marseille, France.
Frédéric BrunelAix-Marseille Université, CNRS, CINAM, 13288 Marseille, France.
Charlotte JeanneauAix-Marseille Université, CNRS, ISM, Inst Movement Sci, 13385 Marseille, France.
Michel CamploAix-Marseille Université, CNRS, CINAM, 13288 Marseille, France.
Michelle SergentAix-Marseille Université, CNRS, IRD, IMBE, 13397 Marseille, France.
Imad AboutAix-Marseille Université, CNRS, ISM, Inst Movement Sci, 13385 Marseille, France.
Jean-Michel BollaAix-Marseille Université, INSERM, SSA, IRBA, MCT, 13005 Marseille, France.ORCID 0000-0003-3892-4340
Jean-Manuel RaimundoAix-Marseille Université, CNRS, CINAM, 13288 Marseille, France.

Funding

SATT-SE 780-SA-16-CNRS
6 · The paper itself

Abstract

Prosthetic implants are widely used in dentistry and orthopedics and, as a result, infections can occur which cause their removal. Therefore, it is essential to propose methods of eradicating the bacteria that remain on the prosthesis during treatment. For this purpose, it is necessary to develop surfaces whose antibacterial activity can be controlled. Herein, we designed innovative and smart phosphonium self-assembled monolayer (SAM) interfaces that can be electrically activated on demand for controlling bacterial contaminations on solid surfaces. Upon electroactivation with a low potential (0.2 V for 60 min., conditions determined through a

Indexed as

Bacterial InfectionsStaphylococcus aureusAnti-Bacterial AgentsBacteriaGram-Negative BacteriaHumansSurface PropertiesTitaniumAnti-Bacterial AgentsTitaniumbiocidal effectelectroactivationphosphoniumsresponsive surfacesself-assembled monolayers

Identifiers

PMID35216303
PMCPMC8879818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.